PureTech thinks the ‘hub-and-spoke’ startup model is still a good bet. If only investors agreed.
BioPharma Drive: Drug Pricing
OCTOBER 21, 2024
Shares in the Boston-based biotech creator, which had a standout success in forming Karuna Therapeutics, trade around cash levels — a "huge value disconnect" its leaders are trying to bridge.
Let's personalize your content